Skip to content

Tamim Rezai

McGill University

2 papers in the library · 66 citations · publishing 2021-2024

Papers

Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice

Journal of Psychopharmacology March 1, 2021 A. Inserra, D. de Gregorio, Tamim Rezai et al. 42 citations

LSD alters the firing patterns of neurons in the reticular thalamus, which controls information flow to the cortex. In anesthetized mice, low doses of LSD decreased activity in half of these neurons, while higher doses increased activity in the other half. This was accompanied by increased firing in the mediodorsal thalamus, a relay station to the cortex. LSD only excited neurons in the prefrontal cortex at the highest dose. A dopamine D2 receptor blocker reversed some effects, suggesting LSD acts partly through this receptor. These changes in thalamocortical gating may explain how LSD alters consciousness in humans.

Epigenetic mechanisms of rapid-acting antidepressants

Translational Psychiatry September 4, 2024 Antonio Inserra, Antonella Campanale, Tamim Rezai et al. 24 citations

Rapid-acting antidepressants, such as dissociative anesthetics, psychedelics, and empathogens, may improve psychiatric disorders by modulating neuroplasticity, neurotransmission, and immunity. Preliminary evidence suggests these drugs are accompanied by epigenetic changes—including alterations in DNA methylation, histone modifications, and non-coding RNA regulation—in stress-responsive brain regions, similar to those seen with conventional antidepressants. Whether these epigenetic changes causally contribute to therapeutic effects, are a consequence, or are unrelated remains unknown. Candidate mechanisms involve neuronal activity, serotonin and TRKB signaling, and direct interaction with chromatin. Causation, cell type-specificity, and mechanisms are largely unconfirmed.